NEW YORK & LEAMINGTON, Ontario–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY; TSX: TLRY) announced that the Company will release financial results for its first quarter fiscal 2022 ended August 31, 2021 before financial markets open on Thursday, October 7, 2021. Tilray executives will host a conference call and live audio webcast to discuss these results at 8:30 am…
As of 11:05 a.m. EDT, shares of Canopy Growth (NASDAQ: CGC) have fallen 5.8%, Tilray (NASDAQ: TLRY) is down 6%, and Aurora Cannabis (NASDAQ: ACB) is bringing up the rear with a 6.3% decline. The past several days have seen a series of cuts to marijuana stock price targets among Wall Street analysts, you see, in advance of Aurora Cannabis’…
Tilray Inc (NASDAQ: TLRY) sent an open letter on August 26 from Irwin D. Simon, CEO and chairman, to the company’s shareholders. In the letter, Simon describes his vision for the company and gives his $4 billion target. He also encourages shareholders to vote for initiatives that are in line with this vision at Tilray’s special meeting of stockholders. The meeting…
Marijuana stocks Sundial Growers (NASDAQ: SNDL), Tilray (NASDAQ: TLRY), and Aurora Cannabis (NASDAQ: ACB) are all hopping in afternoon trading on Tuesday. As of 1:05 p.m. EDT, Sundial was up a solid 4.2%, Tilray had gained 5%, and Aurora Cannabis led the pack with a 5.2% gain. As you’re probably aware, the fate of marijuana legalization legislation in the U.S.…
But that is no guarantee for TLRY stock While Canada becoming the first G7 nation to legalize recreational marijuana represented a boon for cannabis firms like Tilray (NASDAQ:TLRY), the long-term goal has always been breaking into the U.S. Let’s face facts. With a population of under 38 million, Canada just doesn’t have the economic clout that stakeholders of TLRY stock are looking…
What happens if marijuana isn’t the only drug that gets legalized in the US? What happened Marijuana stocks got thrown for a loop on Thursday, and shares of Aurora Cannabis (NASDAQ:ACB) are trading down 3.6% as of 3:40 p.m. EDT, followed by Sundial Growers (NASDAQ:SNDL) with a 4% loss, and Tilray (NASDAQ:TLRY) down 4.4%. So what It’s rarely easy to put your finger on what exactly causes a marijuana stock to go up…
Marijuana stocks got thrown for a loop on Thursday, and shares of Aurora Cannabis (NASDAQ: ACB) are trading down 3.6% as of 3:40 p.m. EDT, followed by Sundial Growers (NASDAQ: SNDL) with a 4% loss, and Tilray (NASDAQ: TLRY) down 4.4%. It’s rarely easy to put your finger on what exactly causes a marijuana stock to go up or down.…
Tilray, Inc. (NASDAQ: TLRY) has bought the majority of the outstanding senior secured convertible notes of MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) that were originally held by certain funds affiliated with Gotham Green Partners, LLC and other funds. The transaction is valued at $165.8 million. Tilray said the purchase sets the company up to own a significant equity position in MedMen…
Tilray Acquires Majority Position in Amended MedMen Convertible Notes Investment Provides Tilray a Potential Accelerated Path into U.S. Cannabis Market Upon Federal Legalization Amendment and Extension of Convertible Notes Enables MedMen to Reshape Balance Sheet and Further Accelerate its Growth Trajectory Tilray and MedMen CEOs to Host a Conference Call and Webcast at 5:00 PM […] READ MORE: https://www.newcannabisventures.com/tilray-to-exchange-9-million-shares-for-165-million-convertible-note-and-warrant-position-held-by-gotham-green-partners/
Exclusive Interview with Tilray Chairman and CEO Irwin Simon The merger of Tilray (NASDAQ: TLRY) (TSX: TLRY) and Aphria closed in May of this year, and now, the combined company is working on growing brands and expanding its business in Canada, Europe and the U.S. Chairman and CEO Irwin Simon last spoke with New Cannabis […] READ MORE: https://www.newcannabisventures.com/irwin-simon-maps-out-path-to-tilrays-potential-4-billion-in-revenue-by-2024/
(Bloomberg) — Tilray Inc. shares surged the most in more than five months as investors rewarded the cannabis company for profiting even amid challenges due to Canada’s Covid-19 restrictions. Net income was $33.6 million for the fiscal fourth quarter ended May 31, compared to a loss of $84.3 million in the year-earlier period, while Ebitda almost quadrupled to $12.3 million,…
Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal. READ MORE: https://finance.yahoo.com/m/6e8fb483-3ff2-3a41-8275-9e9949427873/are-any-marijuana-stocks-on.html?.tsrc=rss